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Service user reflections on the impact of
involvement in research
Jim Gordon1, Sue Franklin1 and Sabrina A. Eltringham1,2*
Plain English summary: Public involvement can impact on research, on the public who give advice, on the
researchers and the research participants. Evaluating impact is an important part of the research process. Two
members of a hospital-based patient research panel and our coordinator have written this paper. Our panel covers
a range of rehabilitation and palliative services. These services form the “Therapeutics and Palliative Care
Directorate”. We describe how we worked collaboratively with hospital staff and co-produced questionnaires to
evaluate the impact of our involvement. We compared the different perspectives of the researchers and panel
members on our contribution to the research. We present evidence from these different standpoints, including
how our panel made a difference. We found we needed to adapt how we collected the views of the researchers
and our members to ensure it was meaningful to our group whilst delivering the wider objective of the hospital. A
key finding has been how our involvement has extended into other groups, which has identified opportunities for
sharing resources and experience, including areas such as cost effectiveness. Our two-person membership of a high
level Board of Academics and Senior Clinicians, which oversees the research we contribute to, has resulted in our
opinions influencing the heart of the Directorate’s research strategy. We have learned the importance of a flexible
approach as the Directorate changes, and the demands on us grow. This will continue to help us share our own
development, successes and experience and extend the benefits from working this way.
Abstract: Background
Reports about the impact of patient and public involvement in research can be improved by involving patients and
research staff more collaboratively to co-produce instruments to measure their involvement. This commentary,
written by two members of a hospital-based patient panel and their coordinator for its work, describes how we co-
produced instruments to evaluate the impact and effectiveness of our involvement. We present here the results,
including our quantitative and qualitative findings, of this patient led evaluation and reflect on how our
involvement has made a difference to the research projects and research infrastructure within the hospital in which
we operate and on us as a panel.
Methods
Existing impact frameworks and guidelines were reviewed. Members co-produced and piloted qualitative
questionnaires to identify values associated with patient and public involvement (PPI) from both a researcher and
panel member perspective, and collected quantitative metrics to provide descriptive statistics on the type of
involvement and activities. Members also produced a comments slip to provide contemporaneous feedback after
each meeting.
Results
The panel has reviewed 36 research projects for the Therapeutics and Palliative Care Directorate drawn from speech
and language therapy, physiotherapy, occupational therapy, dietetics, podiatry, palliative care services and
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chaplaincy. Some of the main results of our involvement have been the development of grant applications and
making written information more understandable for research participants. Examples of how the Panel made a
difference included providing an effective forum for debate by providing practical suggestions to improve research
design and identifying potential issues that may not have occurred to the researcher. The panel has had an impact
outside of meetings both within the context in which it operates and on the individuals involved. Examples
included: influencing the Directorate research agenda, sharing resources with other groups, developing research
relationships, and enabling member participation in different roles and settings.
Discussion
Embedding ourselves within the Directorate research infrastructure has enabled us to adapt to organisational
change and actively contribute to the research strategy. There is greater scope for involvement in areas of cost
effectiveness and economic evaluation. Increasing member contributions and networking with other groups
provides added value as well as cross fertilisation of ideas as part of our widening impact.
Conclusion
Evaluating the impact of our involvement has improved our understanding of what aspects of involvement work
best for the panel and the researchers who attend our meetings, and in the different settings that we work in. It
has helped us to focus on how we need to develop to maximise our resources going forward.
Keywords: Service user, Impact, Involvement
Introduction
Patient and Public Involvement (PPI) can have a range
of impacts. It can impact on research, on the members
of the public who contributed, on the researchers and
research participants, and on the wider community [1].
Increasing evidence about the impact of PPI from the
perspective of service users is emerging [2]. However ac-
counts of impact can be improved by providing more in-
formation about the context and mechanism of
involvement [3] and involving service users collabora-
tively to develop instruments to measure impact [4].
This commentary describes how members of a patient
research panel in a large National Health Service (NHS)
Teaching Hospital worked collaboratively with the Trust
Research Department and other patient research panels
in the hospital to co-produce tools to evaluate the im-
pact of patient involvement from the different perspec-
tives of the researcher and the panel member. We
present the results from the evaluation of our panel and
discuss how our involvement to date has made a differ-
ence to the research projects and research infrastructure
within the hospital in which we operate and on us as a
panel.
The Therapeutics and Palliative Care Patient Research
Panel launched in May 2014 as part of the Directorate’s
investment in its research infrastructure and commit-
ment to integrating service users into the research
process. The Directorate provides a wide range of diag-
nostic, rehabilitation and palliative care services, and
supports patients with a broad spectrum of acute,
chronic and progressive health conditions and diseases.
Members were selected based on their direct experience
of these services or indirect experience as carers of
patients who use these services. These services include
speech and language therapy, physiotherapy, occupa-
tional therapy, dietetics, psychology, chaplaincy, tissue
viability and palliative care services. Many of our mem-
bers are active users of these services or care for some-
one who uses these services so their experiences are
contemporaneous. The panel meets quarterly, but also
offers the facility for members to contribute online for
those who can not attend meetings to provide feedback
and for researchers the opportunity to have access to the
panel between meetings.
The main aim of the panel through face-to-face meet-
ings and providing online feedback between meetings is
to ensure that the research being carried out is high
quality and patient focused. Members are involved
throughout the research process from helping to priori-
tise research topics; offering feedback on research pro-
posals including applications for ethical approval;
providing ideas to improve patient recruitment; to dis-
seminating the findings to the wider public. Another im-
portant part of our remit is to raise staff awareness of
PPI, our panel, and the value of involving patients and
the public in research. We are actively involved in edu-
cational and training activities and events. Additionally
two members of our panel sit on a high level board of
academics and senior clinicians, which oversees the re-
search we contribute to, where they have the opportun-
ity to influence the Directorate’s research strategy.
Evaluating impact is an important part of the research
process [5]. Having contributed to the Directorate’s re-
search for two and half years the panel wanted to know
if they had made a difference and felt they had sufficient
amount of data to form the basis of an evaluation. As
Gordon et al. Research Involvement and Engagement  (2018) 4:11 Page 2 of 6
well as being good practice to measure our intervention
it was felt an evaluation might improve our involvement
by learning from the feedback of researchers as well as
our members. The decision to evaluate our activities also
coincided with a Trust wide initiative to measure the im-
pact of all its panel activities.
Methods
Our co-ordinator attended a meeting with the chairs
and co-ordinators of the other hospital patient research
panels and the Trust’s Research Department to discuss
how the impact of the panels should be measured and
evaluated. Existing impact frameworks and guidelines [1,
6] were reviewed and we co produced with the other
hospital panels and the Research Department separate
qualitative questionnaires for panel members and re-
searchers. The aim of the questionnaires was to identify
the values associated with PPI from a patient and re-
searcher perspective. It was felt important that as part of
the impact framework we should also capture data for
example on the frequency and level of our input on re-
search projects. Information in the form of quantitative
data was collected by our co-ordinator to provide de-
scriptive statistics on panel membership, type of input
into the research process, attendance at local and re-
gional events, and staff educational activities.
Our members piloted the new panel member ques-
tionnaire and the researcher feedback questionnaire. We
commented individually and collectively and our feed-
back was taken back to the joint chair and co-ordinator
working party. Amendments to both questionnaires
were collectively agreed.
Researchers who attend the Therapeutic and Palliative
Care panel meetings are asked to complete their ques-
tionnaire after each meeting. The panel questionnaire is
designed for annual feedback. In addition to the Trust
questionnaire our panel also felt it important to intro-
duce a comments slip to be completed at the end of
each meeting. This was in response to some members
finding it difficult to recall information over twelve
months and wanted to be able to implement change
more quickly. The comments slip asks panel members
what aspects of the meeting did they find most and least
rewarding, and how they feel they made a difference.
Results
Quantitative metrics
The Panel has 14 members and has reviewed 36 research
proposals between May 2014 and March 2017. A total of
33 researchers attended meetings or approached the panel
remotely and a number requested feedback more than
once. The main areas which the panel provides input is in
the design of studies: recruitment of participants, develop-
ing grant applications, reviewing participant materials (for
example, information sheets and consent forms), com-
menting on data collection tools (for example, question-
naires and interview topic guides) and outcome measures
(Fig. 1).
Other types of involvement include prioritising topics
for future research and providing input at a strategic
level, for example by reviewing and commenting on the
Directorate research strategy. Changes to the research
strategy included refocusing the strategy to more
strongly reflect the primary aim of undertaking research
for patient benefit, and including patient relevant out-
come measures. The Directorate achieved Trust Aca-
demic Status in 2016. The review committee
acknowledged clear evidence of the panel’s involvement.
Other examples of involvement have included being a
member of a project’s steering group, attending work-
shops, and disseminating their work at local, regional
and national research and public engagement events.
We have also presented at staff education and training
events including a “Valuing patients in research” work-
shop, in which members of the panel presented the pa-
tient perspective. This educational event has since been
adopted by the Trust Research Department and rolled
out as part of their educational programme.
Qualitative data
Researchers were asked what their perceptions were of
presenting to the panel before and after the meeting.
Most researchers before attending were aware that seek-
ing the opinions of members of the public was an inte-
gral and valuable part of the research process and were
optimistic about potential insights that may not have oc-
curred to them. One researcher felt “apprehensive about
being asked questions I couldn’t answer!” After the
meeting researchers stated they felt the comments were
constructive and supportive: “It encouraged me to perse-
vere with my application”.
Fig. 1 Type of involvement (May 2014 to March 2017)
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Overall 83% of researchers stated they found the
panels comments very useful and 77% made changes as
a consequence of the feedback. Eighty four per cent
stated they were very satisfied with their experience and
94% said they would definitely use the panel again. Ex-
amples of how researchers found the panel’s comments
very useful included consideration of the burden to re-
search participants in a study about developing speech
recognition software for patients with paralysis on
breathing support machines. The panel suggested short-
ening the length of the voice recordings as part of the
software development given potential for participant fa-
tigue, which was favourably received by the research eth-
ics committee. Another example of added value was for
a podiatry research study about peripheral arterial dis-
ease funded by the National Centre for Sport and Exer-
cise Medicine. The panel suggested changes on how to
make the recruitment poster more impactful and alter-
ing the way the participant information sheet was writ-
ten. It was felt some of the language in the information
sheet could be less threatening and might put people off
participating in the study. The researchers took on board
the panel’s advice, changed the participant information
sheet and the study achieved its recruitment target. An
example given from the minority of researchers who did
not find it useful included not having anyone with direct
experience of the condition of the topic of their research
for a study about a triage system using photographic
technology for wound management. Although no panel
members had any personal experience one of our mem-
bers who is carer for her husband who has experience,
was able to offer a carer point of view and was subse-
quently invited to join the project’s steering group.
The most important question for us as panel members
and one we ensured was included in both the panel and re-
searcher questionnaires, was how the panel had made a dif-
ference. Table 1 summarises the themes and practical
examples from the panel and researchers on how the panel
has made a difference to the research.
As a panel we felt we enhanced research proposals by
identifying issues from a user’s perspective that may not
have occurred to researchers. Members felt they im-
proved research studies by proposing suggestions to
minimise selection bias of participants, encouraging a
wider approach to intervention and outcome measures,
and recommending customisation of the recruitment
materials to help recruit and retain participants, and the
use of more patient friendly language in information
sheets. On a personal level some members of our panel
felt their involvement had strengthened their knowledge
of the research process and enabled them to continue to
be part of a professional or academic community, which
they had to prematurely withdraw from due to their
condition or carer commitments. Other personal bene-
fits included feeling they were giving something back to
the National Health Service.
Suggestions on how the panel could be improved in-
cluded: increasing the diversity of its membership from
different social and cultural groups and to target recruit-
ment with direct and indirect experience of different
conditions and services to continue to reflect the
breadth of patients which the Directorate provides ser-
vices for. Researchers liked the range of ways they could
contact the panel through the co-ordinator and re-
quested if this could extend beyond the panel meeting.
A request was made for longer discussion time for cer-
tain research items.
Discussion
Adapting to changes in the context of the research
environment
What we choose to say as panel members, and how well
we fulfil our role, relates to our ability to know and learn
about the organisation and the research context. This
Table 1 How has the Panel made a difference?
Panel Perspective Researcher Perspective
Enhancing research proposals by providing practical suggestions to
improve research design e.g. recruitment, sampling, treatment
approaches, and outcome measures.
Highlighting the benefits and issues to be addressed e.g. selection bias,
data collection tools, information governance issues, and wider
involvement of service users.
Identifying potential issues that may not have occurred to the researcher. Roles and training of members of the research team e.g. conducting
interviews.
Giving a patient perspective and experience e.g. customising materials to
improve recruitment, participant burden, and planned intervention.
Adapting methods of data collection e.g. consistency of language,
number and length of interviews, and focusing on key outcome
measures.
Improving information accessibility for research participants e.g. lay
summaries, participant information sheets, consent forms, and
recruitment materials.
Being inclusive e.g. using more easily understandable language, avoiding
acronyms, creating aphasia friendly information to avoid exclusion.
Reinforcing the importance of the research. Prompted us to seek funding following service user feedback.
Providing an effective forum for debate; concentrating on key elements
from the patient’s perspective.
Reinforced patient engagement and using a co-design methodology.
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has been challenging as the “organisation” has changed
around us. The composition of the Directorate’s services
has evolved and we are now part of a larger Care Group
in the Trust. This has had implications for our workload
and the experience and abilities of panel members to re-
main useful and effective. Adaptation has been success-
fully achieved through the panel and the Directorate
working together through regular consultation on the
changing infrastructure and its likely significance for the
skills and workload of the panel. Trust staff have
adopted a shared information approach and thus fully
engaging us in the process as well as research proposal
content. For example, the Research Lead for the Direct-
orate attends panel meetings and a regular item of the
agenda is scheduled where members can discuss the im-
plications of organisational change with the opportunity
to discuss our ability and willingness to respond. The re-
sult for us has been heightened motivation and enthusi-
asm to adapt including our involvement in panel
recruitment and adjusting the member mix. Thus all
have worked to maintain our panel’s strong cross condi-
tion contribution.
Areas for further involvement
In our view much of the findings and metrics in this
paper are due to our wide remit. We have been
strongly encouraged to question and advise and this
has had a significant impact on the measurement and
improvement of outcomes likely to be more accept-
able, meaningful and understandable for patients.
However we also now see greater scope for our panel
involvement in strengthening research at the input or
research design stage particularly in respect to meth-
odology, especially where this would contribute in the
important areas of cost effectiveness and economic
evaluation.
These may be more challenging and difficult areas
for researchers to bring to the Panel but if consider-
ation of cost and cost-effectiveness are not more fre-
quently part of what researchers consider appropriate
for panels - and we find seldom do at present - then
we ourselves are not being used to maximum effect-
iveness. The panel can play a role in ensuring cost-
effective approaches or treatments are not missed and
are made available to patients. One of the co-authors
of this paper has been influenced in this view through
simultaneous membership of a PPI group for a study
about adaptive design clinical trials and the impact
on the economic evaluation of healthcare technologies
[7]. This is also an example where members extend
their involvement and create links with other patient
panels and cross-fertilise ideas. In going forward we
are keen to ensure that such future opportunities are
not missed.
Setting the research agenda
The panel has been able to influence the research
agenda through representation on the board of aca-
demics and senior clinicians and contribution to the Di-
rectorate’s Research Strategy 2015–2018. This helped it
gain Academic Status. At an inter disciplinary level using
a workshop format, we have provided a patient perspec-
tive in working with speech and language therapists in
narrowing down competing priorities to a manageable
number for their future research program. We envisage
such strategic contributions developing and expanding.
We have been invited to consider producing a panel led
view on research and establishing panel generated ideas
for a research agenda.
Impact on individuals and the group
The experience has been a very rewarding one in the
main. There has been a sense of building working rela-
tionships and partnerships between Trust staff and our-
selves that have been primarily positive and open. We
have concentrated on giving ideas and sharing informa-
tion as opposed to focusing on what is wrong or appear-
ing to criticise. Without holding back on any concerns,
we feel we have gained confidence in contributing con-
structively. Whilst striving to maintain objectivity, we
have appreciated the insight we have been allowed into
the challenges of the NHS environment. Finally there is
gaining considerable satisfaction in being able to “give
something back” through helping staff improve their
proposals and secure approval of funding. These reflec-
tions are consistent with some of the practices of appre-
ciative enquiry [8] in particular where stakeholders such
as us are engaged to determine change by focusing on
what is working well and doing more of it.
Future development and suggestions for improvement
We suggest there is much added value from investment
in the panel through maintaining or increasing the con-
tribution some members are able to make outside the
panel. This is important for the transference of ideas
and knowledge these contributions can create as well as
forging mutually beneficial relationships. This includes
dissemination through participation in public engage-
ment events and more interaction with researchers and
involvement in the research process itself including
membership of steering groups for research trials or be-
ing a subject or volunteer in a study.
This evaluation has identified the importance attached
to maintaining the appropriate gender, age and cultural
balance within the panel as well as the diversity of the
conditions, which the Directorate serves. We have
recognised this as a future priority for us to assist with.
An illustration of the importance the Directorate at-
taches to our involvement is our representation on the
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academic board, including the Chair. Although now well
established, we see this relationship very much develop-
ing in the future: we play a full part in all discussions at
Board level and in turn report to the board as PPI pro-
gresses and is evaluated. Indeed it was as a result of this
that at Board professorial level it was suggested that we
write this paper and put it forward for publication as a
PPI outcome and discussion document worth sharing
with others.
Finally as we gain further experience we anticipate
greater value added from patient panels working to-
gether to gain maximum benefit from our time commit-
ment and the NHS resource investment in our support.
The involvement of our members in other groups has
opened up a network of local, regional and national
links, which is a vital and reciprocal resource for im-
proving patient focussed research and outcomes, and
one which we will continue to foster.
Conclusion
Our involvement in the development of tools to evaluate
our impact has helped ensure that measurements are
meaningful from a service user perspective, and out-
comes important to this group are included. In addition
the results from the evaluation has improved our under-
standing of what aspects of our involvement work best
across different contexts in which we operate, whether
providing feedback to a researcher about the accessibility
of their recruitment materials on a particular researcher
project; to influencing the Directorate’s research agenda.
It has also highlighted areas for improvement. This will
help sharpen our focus on how we need to develop
membership and activities to maximise future resource
investment in our remit and activities. In addition we
feel service user involvement in the provision of advice
about cost and other methodological implications im-
portant to NHS decision making should be prioritised
and that sharing our learning through greater network-
ing with other groups is needed to maximise our own
value, effectiveness and the resource justification for PPI.
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